Innovative methods developed in cancer treatment in recent years are making significant progress in fighting the disease by harnessing the power of the immune system. One of these treatments is... TIL (Tumor Infiltrating Lymphocyte) treatment, This is a personalized cellular immunotherapy method that uses the patient's own immune cells. Promising results are being obtained, particularly in some advanced and treatment-resistant cancer types.
How is TIL Treatment Applied?
In TIL treatment, immune cells that are naturally present within the tumor tissue and capable of fighting cancer cells are isolated using special methods.
The treatment process generally consists of the following stages:
- Sampling of tumor tissue
- Isolation of lymphocytes within the tumor in a laboratory setting.
- Multiplying these cells to the point where their number reaches millions or even billions.
- Administering preparatory treatment to the patient.
- The multiplied immune cells are re-administered to the patient intravenously.
- Administering additional treatments that support the activity of immune cells when needed.
This process is planned in state-of-the-art laboratories and by experienced oncology teams.
In which types of cancer can it be used?
TIL therapy is not a standard treatment for all types of cancer. Suitable patients are determined after a multidisciplinary evaluation.
Cancer types that are the focus of research and clinical practice include:
- Melanoma (advanced skin cancer)
- Cervical cancer
- Some subtypes of lung cancer
- Head and neck cancers
- Bladder cancer
- Some gastrointestinal cancers
With new clinical trials, its use is gradually expanding in different types of cancer.
Who might it be suitable for?
TIL therapy may be considered in some patients with the following characteristics:
- Those diagnosed with advanced or metastatic cancer
- Patients whose disease progresses despite standard treatments
- Patients from whom a sample of tumor tissue can be surgically taken
- Individuals whose general health condition is suitable for cellular therapy.
- Patients deemed suitable for immunotherapy by an oncology specialist.
The final suitability decision is made after a detailed clinical evaluation.
Advantages of TIL Treatment
This treatment method, tailored to the individual, aims to increase the immune system's capacity to target cancer cells.
The advantages it can provide are as follows:
- The patient's own immune cells are used.
- It can generate a strong immune response against cancer cells.
- It can provide long-term disease control in some patients with advanced-stage disease.
- It can offer an alternative option in some cases where resistance to treatment has developed.
- This is a prime example of a personalized treatment approach.
The success of treatment can vary depending on the type and extent of cancer, as well as the patient's overall health.
Possible Side Effects
Some side effects may occur during or after TIL treatment. A significant number of these are related to the preparatory treatments and supportive medications used during the treatment process.
Possible side effects include:
- Fire
- Weakness
- Shake
- Nausea
- Anorexia
- Hypotension
- Temporary drop in blood values.
- Increased risk of infection.
Therefore, the treatment process is closely monitored in experienced centers.
Things to Consider During the Treatment Process
It is extremely important for patients to follow their doctor's recommendations completely throughout their treatment.
The recommendations are as follows:
- Don't miss your check-up appointments.
- Report any signs of infection promptly.
- Eating a balanced diet
- Drink enough fluids.
- Do not use medication without a doctor's recommendation.
- Regular participation in the post-treatment follow-up program.
Close monitoring plays a crucial role in the safety and effectiveness of treatment.
Future Location
Cellular therapies are among the rapidly developing research areas in oncology. TIL therapy is considered one of the most remarkable approaches, particularly in the field of immunotherapy. Thanks to ongoing scientific studies, its use is expected to increase in more cancer types and wider patient groups in the future.
Conclusion
TIL therapy is an innovative and personalized immunotherapy method that utilizes the patient's own immune cells. This approach, which can offer promising results, particularly in some advanced-stage cancers, can be a significant treatment alternative if applied in appropriate patient selection and experienced centers. Suitability for treatment must be determined through medical evaluation and the decision of an oncology specialist.
